Immuron (Australia) Today
| IMC Stock | 0.08 0 2.70% |
Performance0 of 100
| Odds Of DistressLess than 20
|
Immuron is selling for under 0.076 as of the 27th of November 2024; that is 2.70 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.075. Immuron has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Immuron are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of August 2024 and ending today, the 27th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Immuron is entity of Australia. It is traded as Stock on AU exchange. The company has 228 M outstanding shares. More on Immuron
Moving together with Immuron Stock
Moving against Immuron Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Immuron Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Immuron's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Immuron or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Immuron's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Immuron's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsImmuron can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Immuron's financial leverage. It provides some insight into what part of Immuron's total assets is financed by creditors.
| |||||
Immuron (IMC) is traded on Australian Securities Exchange in Australia and employs 7 people. Immuron is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Immuron's market, we take the total number of its shares issued and multiply it by Immuron's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Immuron operates under Biotechnology sector and is part of Health Care industry. The entity has 228 M outstanding shares.
Immuron generates negative cash flow from operations
Check Immuron Probability Of Bankruptcy
Ownership AllocationImmuron has a total of 228 Million outstanding shares. Immuron retains 18.39 (percent) of its outstanding shares held by insiders and 0.0 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Immuron Ownership Details
Immuron Risk Profiles
Although Immuron's alpha and beta are two of the key measurements used to evaluate Immuron's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.62 | |||
| Standard Deviation | 4.27 | |||
| Variance | 18.21 | |||
| Risk Adjusted Performance | (0.08) |
Immuron Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Immuron without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Immuron Corporate Management
Elected by the shareholders, the Immuron's board of directors comprises two types of representatives: Immuron inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Immuron. The board's role is to monitor Immuron's management team and ensure that shareholders' interests are well served. Immuron's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Immuron's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA | Chief Officer | Profile | |
| Jerry Kanellos | Chief Officer | Profile | |
| Dan Peres | Chief Officer | Profile | |
| Flavio Palumbo | Chief Officer | Profile | |
| David Lyon | Head Marketing | Profile |
Additional Tools for Immuron Stock Analysis
When running Immuron's price analysis, check to measure Immuron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuron is operating at the current time. Most of Immuron's value examination focuses on studying past and present price action to predict the probability of Immuron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuron's price. Additionally, you may evaluate how the addition of Immuron to your portfolios can decrease your overall portfolio volatility.